NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 140 filers reported holding NOVAVAX INC in Q2 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $48,000 | -79.0% | 41,326 | -76.9% | 0.00% | -83.3% |
| Q1 2017 | $229,000 | +166.3% | 178,797 | +161.0% | 0.01% | +200.0% |
| Q4 2016 | $86,000 | -67.2% | 68,505 | -45.7% | 0.00% | -66.7% |
| Q3 2016 | $262,000 | -60.5% | 126,102 | +38.3% | 0.01% | -57.1% |
| Q2 2016 | $663,000 | +83.1% | 91,176 | +30.0% | 0.01% | +40.0% |
| Q1 2016 | $362,000 | +45.4% | 70,129 | +136.3% | 0.01% | +150.0% |
| Q4 2015 | $249,000 | -89.1% | 29,679 | -90.8% | 0.00% | -89.2% |
| Q3 2015 | $2,290,000 | +1216.1% | 323,895 | +1435.8% | 0.04% | +825.0% |
| Q1 2015 | $174,000 | -72.5% | 21,089 | -86.1% | 0.00% | -66.7% |
| Q3 2014 | $632,000 | +485.2% | 151,561 | +546.3% | 0.01% | +500.0% |
| Q2 2014 | $108,000 | +21.3% | 23,452 | +34.5% | 0.00% | +100.0% |
| Q4 2013 | $89,000 | -62.6% | 17,437 | -76.9% | 0.00% | -66.7% |
| Q3 2013 | $238,000 | – | 75,431 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |